DermalRx® SRC-R
Next-Generation Gentle Skin Resurfacing
© paulaphoto/AdobeStockDermalRx SRC-R® is a biotech-derived active ingredient based on fermented oligopeptides that supports the skin’s natural renewal process for a smoother, more radiant-looking complexion. As an alternative to traditional acid-based exfoliation, it enables gentle skin resurfacing for advanced anti-aging, brightening, and skin-perfecting formulations.
Through its targeted mode of action, DermalRx SRC-R® helps loosen rough, keratinized surface cells while promoting a more refined and even skin texture. This versatile ferment-based active is ideal for serums, creams, eye care products, and skin renewal treatments, offering formulators new opportunities to develop high-performance skincare solutions with a gentle approach.
DermalRx® SRC-R
Cosmetic benefits
- biofermentation-derived oligopeptide from a proprietary yeast strain
- boosts skin renewal by supporting natural exfoliation
- clinically proven anti-aging efficacy
- visible reduction in wrinkle depth and pigmentation after 14 and 28 days
- increases skin radiance by up to 43% after 28 days
- non-irritating and suitable for the eye area
- not available in every country
DermalRx® FSE HH is a trademark of Biocogent, LLC, used under license.
® – Registered in the U.S. Patent and Trademark Office and in other countries
Product characteristics
| Article-Nr. | 7435 |
| INCI | Aqua, Saccharomyces Ferment Filtrate |
| Compliance | China NMPAVEGAN |
| Appearance, odour | translucent to slightly hazy pale yellow to brown liquid |
| Solubility | water miscible, add below 50 °C |
| Use concentration | 1 - 4 % |